I agree that this site is using cookies. You can find further informations here.
X
Sawalha, Yazeed
70  results:
Search for persons X
?
1

Postinfusion PD-1+ CD8+ CAR T cells identify patients respo..:

Denlinger, Nathan ; Song, No-Joon ; Zhang, Xiaoli...
Blood Advances.  8 (2024)  12 - p. 3140-3153 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Outcomes of Patients with ALK+ Anaplastic Large Cell Lympho..:

Sorrell, Mckenzie ; Ip, Andrew ; Stuver, Robert...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S363-S364 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Siltuximab Prophylaxis Prior to Standard of Care CD19 Direc..:

Voorhees, Timothy ; Huang, Ying ; Denlinger, Nathan...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S355-S356 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Prognostic relevance of circulating lymphoma cells at diagn..:

Annunzio, Kaitlin ; Bhatta, Subodh ; Hanel, Walter...
Hematological Oncology.  42 (2024)  3 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
5

Impact of diagnosis to treatment interval in patients with ..:

Epperla, Narendranath ; Switchenko, Jeffrey ; Bachanova, Veronika...
Blood Advances.  7 (2023)  11 - p. 2287-2296 , 2023
Link: https://doi.org/10.1182/..
 
?
6

Outcomes of patients with blastoid and pleomorphic variant ..:

Gerson, James N. ; Handorf, Elizabeth ; Villa, Diego...
Blood Advances.  7 (2023)  24 - p. 7393-7401 , 2023
Link: https://doi.org/10.1182/..
 
?
7

A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with..:

Hanel, Walter ; Shindiapina, Polina ; Bond, David A....
Cancers.  15 (2023)  5 - p. 1437 , 2023
Link: https://doi.org/10.3390/..
 
?
8

Postibrutinib relapse outcomes for patients with marginal z..:

Epperla, Narendranath ; Zhao, Qiuhong ; Chowdhury, Sayan Mullick...
Blood Advances.  7 (2023)  1 - p. 88-91 , 2023
Link: https://doi.org/10.1182/..
 
?
9

Outcomes associated with allogeneic hematopoietic stem cell..:

Faisal, Muhammad Salman ; Hanel, Walter ; Voorhees, Timothy...
Cancer Medicine.  12 (2023)  7 - p. 8228-8237 , 2023
Link: https://doi.org/10.1002/..
 
?
10

P1071: COMBINATION OF PD-1 INHIBITION WITH IMMUNOMODULATORY..:

Bond, David ; Yildiz, Vedat ; Wei, Lai...
HemaSphere.  7 (2023)  S3 - p. e1419630 , 2023
Link: https://doi.org/10.1097/..
 
?
11

Impact of circulating lymphoma cells at diagnosis on outcom..:

Nalin, Ansel ; Zhao, Qiuhong ; Voorhees, Timothy...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
12

Impact of detectable monoclonal protein at diagnosis on out..:

Epperla, Narendranath ; Zhao, Qiuhong ; Karmali, Reem...
Blood Advances.  7 (2023)  17 - p. 5038-5046 , 2023
Link: https://doi.org/10.1182/..
 
?
13

P1144: PHASE 2 WAVELINE-004 STUDY: ZILOVERTAMAB VEDOTIN (MK..:

Ozcan, Muhit ; Song, Yuqin ; Tae Lee, Seung...
HemaSphere.  7 (2023)  S3 - p. e03345ef , 2023
Link: https://doi.org/10.1097/..
 
?
14

Treatment of primary mediastinal B-cell lymphoma with dose-..:

Annunzio, Kaitlin ; Cackovic, Michael ; Bond, David...
Blood Advances.  7 (2023)  10 - p. 2241-2244 , 2023
Link: https://doi.org/10.1182/..
 
?
15

A multicenter analysis of the outcomes with venetoclax in p..:

Sawalha, Yazeed ; Goyal, Subir ; Switchenko, Jeffrey M....
Blood Advances.  7 (2023)  13 - p. 2983-2993 , 2023
Link: https://doi.org/10.1182/..
 
1-15